Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
J Pharmacol Sci 127:3641 Wu N h, Ye Y, Wan B b et al (2021) Emerging benefits: pathophysiological functions and target drugs of the Sigma-1 receptor in neurodegenerative diseases
It is classified as an investigational research compound intended solely for use by qualified researchers in controlled, non-clinical laboratory environments
While individual responses vary, evidence-based guidelines provide a solid starting framework for most research applications
Most common adverse reactions are transient and typically subside as the subject adapts to the compound
Together, these factors can significantly affect your healthspan
US$ 20.60
US$ 27.06
US$ 22.94
